Eli Lilly and Company

Sr. Director - Global Diagnostics Pathways and Policy

Chester, Maryland, United States

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Company Overview

  • Company Name: Lilly
  • Headquarters: Indianapolis, Indiana
  • Mission: To unite caring with discovery to make life better for people around the world.
  • Focus: Discovering and bringing life-changing medicines, improving disease understanding and management, and giving back to communities.
  • Values: Giving best effort, putting people first, and a determination to make life better globally.

Position Overview

  • Location Type: Not Specified
  • Job Type: Full time
  • Salary: Not Specified

The Sr. Director - Global Diagnostics Pathways & Policy will be responsible for developing strategic plans to address patient access and affordability barriers to diagnostic testing. This role requires up-to-date knowledge of the global diagnostic coverage and reimbursement ecosystem to support key markets in initiative creation and prioritization, ultimately supporting innovation and launch readiness for biomarker-directed medicines.

Responsibilities

  • Act as a central expert on diagnostic coverage and affordability across business units and global teams.
  • Deliver global strategies to improve diagnostic access and remove affordability barriers.
  • Strategically guide and oversee all company-sponsored testing activities.
  • Integrate diagnostic pathway and policy insights into launch readiness planning.
  • Identify and outline early diagnostic coverage and affordability issues for pipeline assets to support New Product Planning.
  • Consult on Lilly-sponsored research and studies to overcome evidence and confidence barriers for diagnostic pathways as part of integrated evidence generation planning.
  • Monitor and provide insights on the global policy, Payer, HTA, and health economic landscape to understand drivers and barriers to appropriate diagnostic testing across various therapy areas and key markets.
  • Ensure diagnostic access, affordability, and policy insights are captured in primary market research and measurement.
  • Own oversight of the global policy, Payer, HTA, and health economic landscape for potential access drivers and barriers to appropriate diagnostic testing.
  • Develop expertise and share insights with cross-functional business partners on macro trends in the diagnostic pathway landscape (e.g., coverage policies, market trends, HTA decisions, health economic studies).
  • Measure and evaluate global key performance initiatives to assess the success of diagnostic pathway initiatives for innovation and launch readiness.
  • Collaborate with LVA teams and Corporate and Government Affairs partners to provide diagnostic policy advisory across the enterprise.

Minimum Qualifications

  • Bachelor’s Degree
  • Minimum of 4 years of relevant experience in market access and/or policy within the diagnostics space.
  • Qualified applicants must be authorized to work in the United States on a full-time basis. Lilly will not provide support for or sponsor work authorization.

Application Instructions

  • Lilly encourages employees to view and apply to open roles posted in the internal job posting system.
  • Employees must meet the minimum qualifications outlined in the job description and have/obtain work authorization in the country the position is to be considered.
  • The current supervisor will be notified upon application. Employees are encouraged to discuss the opportunity with their supervisor prior to applying.

Skills

Diagnostic policy
Pathways strategy
Patient access
Reimbursement ecosystem
Biomarker-directed medicines
Global healthcare strategy

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI